Medicare Formulary Improvement Act of 2015 2015-03-04 Introduced in Senate Medicare Formulary Improvement Act of 2015

This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require a sponsor offering a prescription drug plan (PDP) to include all covered part D drugs in the following categories and classes of drugs in the formulary: (1) anticonvulsants, (2) antidepressants, (3) antineoplastics, (4) antipsychotics, (5) antiretrovirals, and (6) immunosuppressants for the treatment of transplant rejection. Currently the Secretary of Health and Human Services is required to identify categories and classes of drugs of clinical concern.

The Secretary is required, however, to establish any exceptions that permit a PDP sponsor to exclude from its formulary a particular covered part D drug only through promulgation of a regulation, including a public notice and comment period.

]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.